PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in PharmaCyte Biotech, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −5 vs. Q3 2024
- Shares held
- 600.8K
- −225.3K (−27.3%) vs. Q3 2024
- Total value
- $934.3K
- −$642.6K (−40.8%) vs. Q3 2024
- New holders
- 1
- 2 more added
- Sold out
- 6
- 9 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 98 | $0 | 0.00% | −2−2.0% | Reduced |
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 275 | $0 | 0.00% | +49+21.7% | Added |
| Caldwell Sutter Capital, Inc. | 2 | $3 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2 | $4 | 0.00% | 00.0% | Unchanged |
| BFSG, LLC | 5 | $8 | 0.00% | 00.0% | Unchanged |
| Sachetta, LLC | 14 | $22 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 18 | $28 | 0.00% | 00.0% | Unchanged |
| Park Square Financial Group, LLC | 37 | $58 | 0.00% | +37 | New |
| Bank of America Corp | 78 | $123 | 0.00% | −39−33.3% | Reduced |
| Advisor Group Holdings, Inc. | 537 | $841 | 0.00% | +29+5.7% | Added |
| UBS Group AG | 1,874 | $2.94K | 0.00% | −6,480−77.6% | Reduced |
| Tower Research Capital LLC (TRC) | 2,445 | $3.84K | 0.00% | −415−14.5% | Reduced |
| Northern Trust Corp | 19,208 | $30.2K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 25,700 | $40.3K | 0.00% | −200−0.8% | Reduced |
| Dimensional Fund Advisors LP | 26,841 | $41.6K | 0.00% | −760−2.8% | Reduced |
| Susquehanna International Group, LLP | 34,481 | $53.4K | 0.00% | −747−2.1% | Reduced |
| Renaissance Technologies LLC | 49,300 | $77.4K | 0.00% | −400−0.8% | Reduced |
| Equitec Proprietary Markets, LLC | 82,727 | $129.9K | 0.88% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 164,736 | $255.4K | 0.00% | −3,464−2.1% | Reduced |
| Vanguard Group Inc | 192,387 | $298.2K | 0.00% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −209,266−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −2,851−100.0% | Sold out |
| Aspire Private Capital, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Maryland Capital Advisors Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Carolina Wealth Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Planning Capital Management Corp | – | – | – | – | Not filed |